Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

China flag China · Delayed Price · Currency is CNY
139.31
+4.31 (3.19%)
Jun 30, 2025, 2:45 PM CST
425.90%
Market Cap 11.96B
Revenue (ttm) 488.02M
Net Income (ttm) -220.07M
Shares Out 88.60M
EPS (ttm) -2.33
PE Ratio n/a
Forward PE n/a
Dividend 0.20 (0.15%)
Ex-Dividend Date n/a
Volume 2,105,037
Average Volume 3,598,026
Open 135.00
Previous Close 135.00
Day's Range 133.02 - 140.50
52-Week Range 22.94 - 164.28
Beta 1.54
RSI 49.50
Earnings Date Aug 29, 2025

About Beijing Hotgen Biotech

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, mi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 903
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688068
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.